Director, See Remarks · Xeris Biopharma Holdings, Inc. · Common Stock
Side
F
Value
$296K
Shares
36.6K
Price
$8.08
Executed
Aug 1, 2026
Disclosed
Aug 21, 2026
Disclosure timeline20 days from execution to publication · legal deadline 2 business days
Aug 1 executedAug 21, 2026 disclosed
XERS · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Tax withholding — administrative, little informational value
Relative size+7 / 25
$296K reported value · 1.3% of prior position
Filing timing+10 / 15
Disclosed 15 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
Shannon John Patrick Jr filed this Form 4 reporting a tax withholding of XERS on Aug 1, 2026. It became public on Aug 21, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Director, See Remarks
Shannon John Patrick Jrcik:0001553595
Issuer
Xeris Biopharma Holdings, Inc.cik:0001867096
Revision history · 0
No field has changed since this record was first ingested.
